These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 8126121)

  • 1. Characterization of mutant androgen receptors causing partial androgen insensitivity syndrome.
    De Bellis A; Quigley CA; Marschke KB; el-Awady MK; Lane MV; Smith EP; Sar M; Wilson EM; French FS
    J Clin Endocrinol Metab; 1994 Mar; 78(3):513-22. PubMed ID: 8126121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single base mutations in the human androgen receptor gene causing complete androgen insensitivity: rapid detection by a modified denaturing gradient gel electrophoresis technique.
    De Bellis A; Quigley CA; Cariello NF; el-Awady MK; Sar M; Lane MV; Wilson EM; French FS
    Mol Endocrinol; 1992 Nov; 6(11):1909-20. PubMed ID: 1480178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity.
    Brown TR; Lubahn DB; Wilson EM; French FS; Migeon CJ; Corden JL
    Mol Endocrinol; 1990 Dec; 4(12):1759-72. PubMed ID: 2082179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practical approach to the detection of androgen receptor gene mutations and pedigree analysis in families with x-linked androgen insensitivity.
    Ris-Stalpers C; Hoogenboezem T; Sleddens HF; Verleun-Mooijman MC; Degenhart HJ; Drop SL; Halley DJ; Oosterwijk JC; Hodgins MB; Trapman J
    Pediatr Res; 1994 Aug; 36(2):227-34. PubMed ID: 7970939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain.
    Murono K; Mendonca BB; Arnhold IJ; Rigon AC; Migeon CJ; Brown TR
    Hum Mutat; 1995; 6(2):152-62. PubMed ID: 7581399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.
    Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O
    J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression and normal nucleotide sequence of androgen receptor gene coding and promoter regions in a family with partial androgen insensitivity syndrome.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Hurley DM
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):281-8. PubMed ID: 9156036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
    Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes.
    Kazemi-Esfarjani P; Beitel LK; Trifiro M; Kaufman M; Rennie P; Sheppard P; Matusik R; Pinsky L
    Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability.
    Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution (gly743 --> val) in the steroid-binding domain of the human androgen receptor leads to Reifenstein syndrome.
    Nakao R; Yanase T; Sakai Y; Haji M; Nawata H
    J Clin Endocrinol Metab; 1993 Jul; 77(1):103-7. PubMed ID: 8325932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
    Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete androgen insensitivity due to deletion of exon C of the androgen receptor gene highlights the functional importance of the second zinc finger of the androgen receptor in vivo.
    Quigley CA; Evans BA; Simental JA; Marschke KB; Sar M; Lubahn DB; Davies P; Hughes IA; Wilson EM; French FS
    Mol Endocrinol; 1992 Jul; 6(7):1103-12. PubMed ID: 1508223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome.
    Tincello DG; Saunders PT; Hodgins MB; Simpson NB; Edwards CR; Hargreaves TB; Wu FC
    Clin Endocrinol (Oxf); 1997 Apr; 46(4):497-506. PubMed ID: 9196614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An androgen receptor mutation causing androgen resistance in undervirilized male syndrome.
    Tsukada T; Inoue M; Tachibana S; Nakai Y; Takebe H
    J Clin Endocrinol Metab; 1994 Oct; 79(4):1202-7. PubMed ID: 7962294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling.
    Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype versus phenotype in families with androgen insensitivity syndrome.
    Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mosaicism due to a somatic mutation of the androgen receptor gene determines phenotype in androgen insensitivity syndrome.
    Holterhus PM; Brüggenwirth HT; Hiort O; Kleinkauf-Houcken A; Kruse K; Sinnecker GH; Brinkmann AO
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3584-9. PubMed ID: 9360511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.